Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary

Autor: Gary Cook, N. Sriskandan, Selvam Thavaraj, Steve Connor, Richard Oakley, J.P. Jeannon, Mary Lei, Joel Dunn, Ata Siddiqui, Teresa Guerrero-Urbano, Teresa Szyszko, D. Pencharz
Rok vydání: 2018
Předmět:
Adult
Male
Tonsillar Carcinoma
Palatine Tonsil
Malignancy
Sensitivity and Specificity
Palatine tonsil
030218 nuclear medicine & medical imaging
Diagnosis
Differential

03 medical and health sciences
0302 clinical medicine
stomatognathic system
Fluorodeoxyglucose F18
Positron Emission Tomography Computed Tomography
Biopsy
medicine
Humans
Radiology
Nuclear Medicine and imaging

In patient
Aged
Retrospective Studies
Aged
80 and over

Receiver operating characteristic
medicine.diagnostic_test
business.industry
Squamous Cell Carcinoma of Head and Neck
Reproducibility of Results
Retrospective cohort study
General Medicine
Middle Aged
medicine.disease
Head and neck squamous-cell carcinoma
medicine.anatomical_structure
Head and Neck Neoplasms
030220 oncology & carcinogenesis
Neoplasms
Unknown Primary

Female
Radiopharmaceuticals
business
Nuclear medicine
Zdroj: Pencharz, D, Dunn, J, Connor, S, Siddiqui, A, Sriskandan, N, Thavaraj, S, Jeannon, J-P, Oakley, R, Lei, M, Guerrero-Urbano, T, Cook, G J & Szyszko, T A 2018, ' Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary ', Clinical Radiology . https://doi.org/10.1016/j.crad.2018.10.007
ISSN: 1365-229X
Popis: AIM: To analyse the maximum standardised uptake value (SUVmax) ratio between tonsils in patients with and without tonsillar carcinoma to determine useful diagnostic thresholds.MATERIALS AND METHODS: Positron-emission tomography (PET)/computed tomography (CT) examinations of patients with suspected head and neck squamous cell carcinoma (SCC) and controls from April 2013 to September 2016 were reviewed retrospectively. Tonsillar SUVmax ratios (ipsilateral/contralateral for malignant tonsils, maximum/minimum for patients without [controls]) were calculated and used to construct a receiver operating characteristic (ROC) curve.RESULTS: Twenty-five patients had tonsillar carcinoma (mean SUVmax ratio of 2, range 0.89-5.4) and 86 patients acted as controls (mean SUVmax ratio of 1.1, range 1-1.5). Using the ROC, the most accurate SUVmax ratio for identifying malignancy was >1.2 (77% sensitivity, 86% specificity). A potentially more clinically useful SUVmax ratio is ≥1.6 with 62% sensitivity and 100% specificity.CONCLUSION: An SUVmax ratio between tonsils of ≥1.6 is highly suspicious for SCC and could be used to direct site of biopsy. Some malignant tonsils had normal FDG uptake; therefore, PET/CT should not be used to exclude tonsillar cancer. Minor asymmetrical uptake is frequently seen in non-malignant tonsils and does not necessarily require further investigation. Due to the single centre nature of this study and the recognised variation in SUV measurements between PET scans, other centres may need to develop their own cut-offs.
Databáze: OpenAIRE